I am a man of my word. MVP DTC Chill/Lock  SEC crap is

New Post Public Reply Private Reply Replies (1) Message Board
tamerg

I am a man of my word. MVP DTC Chill/Lock  SEC crap is back, so I reported him for a third time.  I am tired of this crap.   Unless proof is proved to the contrary, I will continue to report him.

 

TCR Submitted Successfully - Reference Number: TCR1338909654324
Tell us about your complaint
Please select the option that best describes your complaint
Manipulation of a security
Please select the specific category that best describes your complaint
Other
Please provide more information:
Manipulation of Stock through false information
Provide additional details about your complaint:
On the investment message board for Baron Capital Enterprises on website Investorshub. There is a user by the name of MVP Stocks who is continually posting that SEC is investigating Baron and DTC chill/lock is coming soon, as well as accusing the CEO of being a criminal. Today this was his post: ` "to perpetuate this crime... it takes a low down scum bag with no morals. dwyer. he lost all credibility and is a proven fraud now yet still pays people off to help him continue this scam. too bad most investors are sharp with a good head on their shoulders and can rightfully discern the truth from the repackaged press releases and confusing language dwyer publicizes. the SEC owns baron capital forever. and its not letting it go. dtc lock so soon now. i can hear the footsteps coming" These posts never have any facts associated with them. MVP Stocks posts comments like the one above on daily basis, multiple times a day. Baron is a micro cap and this type of false, defamatory comments could be affecting the volume and/or share price of BCAP. These comments could force new investors from not investing in company as well as shaking shareholder confidence.
Are you having or have you had difficulty in getting access to your funds or securities?
No
Did you suffer a loss?
No
Is the alleged conduct ongoing?
Yes
What is the source of your information? You may select more than one
Social media (e.g., Facebook, Twitter, blogs, chat rooms, and electronic communities of interest);
Have you taken any action regarding your complaint? You may select more than one
Complained to SEC; Complained to other;
Who did you contact and what action did you take?
I have reported this activity to SEC before and it has not stopped. I also posted in the message board several times that if these statements did not cease, I would begin to report these actions to the SEC. I am not a lawyer or familiar with SEC laws. I believe this is stock manipulation, but do not know for sure until you tell me if I am right to report this actions or not. I do not wish to waste the SEC's time, if these actions are not in violation.
Who are you complaining about?
Are you complaining about an individual or a firm?
Individual
Select the title that best describes the individual or firm that you are complaining about:
Other
For Other Individual, please specify:
MVP Stocks, message board user

Baron Capital Enterprise, INC. (BCAP) Stock Research Links

BCAP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Q32 Bio Eyes New Horizons with Bempikibart's Potentials

Updated Category News Views 69

Q32 Bio Steers Forward: New Insights from Chief Results Today's update isn't just another quarterly snooze-fest—it’s a nudge in a crucial direction for Q32 Bio (NASDAQ:QTTB). After a bold brush with the European Academy of Dermatology and Venereology (EADV) Congress 2026, the company laid out a plan and a half, showing its hand with bempikibart for alopecia areata...

Continue Reading
First Industrial Declares Regular Dividend Amid Growth Insights

Updated Category News Views 116

Dividend Declaration Reflects Confidence First Industrial Realty Trust, folks, just put another office stamp on their ongoing reliability quest—and I'm talking dividends. They're shelling out a tidy $0.50 per share for Q4 2026, with stockholders due to see the cash on January 19, 2027. That's like clockwork precision, showing a steadiness in what some call the unruly...

Continue Reading
Toufayan's Sourdough Pita: A Century-Old Recipe Revival

Updated Category News Views 23

Crafting Tradition in Modern Times Ever see a family business stick to its roots despite the whirlwind of fleeting trends? Step aside, because Toufayan isn’t just baking bread—they're pulling a Houdini act, bringing a recipe out of the past and into our grocery aisles. By launching their Simply Sourdough pita, these folks are banking on good ol’ nostalgia and...

Continue Reading
Japan's RWE Market Transformation: TXP's Insightful Whitepaper

Updated Category News Views 55

Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...

Continue Reading
Askey & Icom Team Up: Trading Airwaves for Partnerships

Updated Category News Views 28

Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...

Continue Reading
Acuity Analytics Charts Ambitious AI-Driven Future

Updated Category News Views 128

The New Era at Acuity Analytics Has Begun Isn't it something when a company decides to shake things up in such a daring way? Acuity Analytics just gave the financial sector a reason to sit up and pay attention. They've brought in Jon O'Donnell as the new Chief Executive Officer, a move that's got the city talking. O'Donnell is no rookie; he's a former IBM heavyweight and...

Continue Reading
A Journey Through Mongolia's Wilderness and Self-Discovery

Updated Category News Views 57

A Late-Life Adventure Without Borders We all hit that age where adventure seems just a memory—until something shakes us from our slumber, just like Betsy Cooksey’s wild ride into Mongolia. At an age when most tether their dreams to sunlit porches and grandkids' photos, Cooksey grabbed life by the reins. First, though, we gotta talk about the absolute gamble she took....

Continue Reading
Lone Star's Debrief IQ: Revamping Military Training

Updated Category News Views 20

A Milestone for Military Pilot Training In the grand scheme of military pilot training, Debrief IQ from Lone Star Analysis is making waves. Apparently, they're shaving off a hefty 35 minutes of the grind instructors typically endure post-training sessions. I bet the flight schools are letting out a collective sigh of relief. Years of Frustration Handled by AI So, what's...

Continue Reading
Tigo Energy Faces Legal Heat Over Fraud Allegations

Updated Category News Views 142

Tigo Energy's Legal Battle Heats Up If you haven't been paying attention, it’s time to get your eyes on Tigo Energy (NASDAQ: TYGO). The company is now in the hot seat with a securities fraud lawsuit that's got investors on edge. This isn’t just a minor squabble; we're talking about allegations that could shake the ground beneath its share price. The Claims and...

Continue Reading
AI Shift: From Tech Marvels to Practical Uses

Updated Category News Views 80

A New Chapter in the AI Narrative Take a seat, folks, because we're watching AI swing from showy tech to something as plain as plumbing infrastructure. Imagine models that once cost bundles per token now going for peanuts. We're talking a nosedive from $37.50 to a mere 18 cents. It’s a seismic shift, steering the conversation from 'Are they the best models?' to 'How...

Continue Reading

Top 5 Most Recently Viewed Articles

Angel Oak Financial Strategies Hits New High of $13.35

Updated Category News Views 193

Angel Oak Financial Strategies Reaches New Heights Shares of Angel Oak Financial Strategies (FINS) have achieved a remarkable milestone by reaching a 52-week high, trading at an impressive $13.35. This significant growth is a testament to the company’s strong performance in the financial market. Investors are celebrating as they witness this increase, which stands as a...

Continue Reading
Indonesian Market Update: IDX Composite Index Drop Analyzed

Updated Category News Views 263

Overview of the Indonesian Stock Market's Recent Performance On a recent trading day, the Indonesian stock market experienced a notable decline, with the IDX Composite Index sliding 1.08%. This downtrend was largely influenced by losses in significant sectors such as Financials, Infrastructure, and Agriculture. Understanding these dynamics is essential for investors and...

Continue Reading
Eagle Bancorp Teams Up for Major Financial Conference in November

Updated Category News Views 103

Eagle Bancorp to Feature at Notable Financial Conference Eagle Bancorp, Inc. (NASDAQ: EGBN), the prominent holding company of EagleBank, is gearing up to participate in an influential financial event. This conference, the Piper Sandler East Coast Financial Services Conference, takes place over several days, offering a platform for significant discussions within the...

Continue Reading
Breathe Drops: A Game-Changer for Respiratory Wellness

Updated Category News Views 295

Introducing Breathe Drops: A Revolutionary Wellness Solution In the ever-evolving world of wellness, Breathe is thrilled to unveil its latest product, Breathe Drops. This unique formula aims to enhance lung health and respiratory wellness by harnessing the power of carefully selected natural ingredients. Designed for individuals seeking natural wellness solutions, Breathe...

Continue Reading
Keros Therapeutics to Showcase Innovations at Health Conference

Updated Category News Views 132

Keros Therapeutics to Showcase Innovations at Health Conference During an important upcoming event, Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, will highlight its ongoing commitment to developing novel therapeutics aimed at treating conditions tied to dysfunctional signaling of the transforming growth factor-beta (TGF-ß) protein...

Continue Reading